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Esophageal cancer and its treatment have a profound
impact not only on a patient’s length of life, but quality of
life as well. Dysphagia, weight loss, and eating restrictions
are frequent sequelae of both the disease and its treatment.
In this issue, investigators from the Academic Medical
Center in Amsterdam examined quality of life before and
after resection for distal esophageal cancers.
1 They found
that among preoperative patients, the quality-of-life phys-
ical symptom scale predicted postoperative overall survival
independent of the tumor length and endoscopic ultrasound
T-stage. After surgical resection, the quality-of-life pain
scale, social function, and activity level predicted overall
survival independent of pathological T-stage and N-stage.
Clearly, self-reported health-related quality of life
(HRQoL) adds predictive value to our best available pre-
operative and postoperative prognosticators. The challenge
is how to use this information.
One important beneﬁt of quality-of-life research is to
help evaluate the outcomes of different therapies, such as
the analysis by the same investigators who examined
quality of life after transhiatal compared with transthoracic
esophagectomy.
2
It is intriguing to speculate about what mechanisms may
underlie the effects of HRQoL on overall and disease-
speciﬁc survival. These speculations may help to generate
hypotheses for further investigation that may help further
understand tumor biology.
One mechanism of these interactions may be that quality
of life is a marker for occult metastatic disease. Recent
advances in serum proteonomics in gastrointestinal cancer
patients suggest that even among patients thought to
have localized disease, cancer-associated proteins can be
detected within the serum.
3 It would be reasonable to
assume that even localized tumors, in patients with imag-
ing negative for distant disease, might elaborate serum
factors that would adversely affect quality of life. As this
ﬁeld grows and speciﬁc proteins are identiﬁed, it will be
interesting to see whether the age-old problem of cancer-
associated cachexia can be more fully understood.
Health-related quality of life may also be a window into
the patient’s host response to their neoplasm. Social
function, activity level, and pain may be surrogates for
their ability to recover from surgery and the presence of
major or subclinical surgical complications. Postoperative
decrements in quality of life may also be a marker for
postoperative complications, which are known to affect
quality of life and alter prognosis, even subsequent to the
perioperative period.
4,5
On the other hand, social function and activity level
may be related to cancer-related alterations in circadian
rhythms. Circadian rhythm alterations and social function
are related in complex ways: social cues help to reset the
biological clock, while disruptions in circadian and sleep
cycle patterns tend to affect social interactions. It been
shown, for instance, that cancer patients exhibit abnor-
malities in circadian rhythm function.
6 Disruption in
circadian rhythm function in animals (by ablation of the
suprachiasmatic nucleus) leads to faster tumor growth,
presumably through neuroimmunological pathways.
7 In a
recent study of 192 patients with metastatic colon cancer,
circadian rhythm dysfunction was measured with a 24-h
actigraph afﬁxed to a patient’s wrist. Alterations in circa-
dian rhythm were associated with shorter survival and
worse measures of global quality of life, social function,
fatigue, and pain.
8
The poor prognosis associated with postoperative pain
may also be an indicator of the complex relationship
between pain and cancer biology. The presence of pain
appears to induce immune dysfunction, which may affect
tumor growth. An intriguing report involves the initial
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resulting liver metastases. After tumor injection, laparot-
omy was performed with inhalation general anesthesia
either alone or supplemented with spinal blockade.
9 In
those mice treated with spinal blockade, fewer liver
metastases developed. Immunological studies documented
better preservation of natural killer cell activity and Th1/
Th2 balance in animals treated with spinal blockade. While
these possible mechanisms have not been demonstrated
in clinical research, they do help to generate testable
hypotheses in human cancer research.
In summary, the article in this issue of Annals of Sur-
gical Oncology emphasizes the growing awareness that
health-related quality of life may not only play a role in
providing prognostic information for cancer patients, but
may give us some insight into cancer biology.
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